Obesity Clinical Trial
Official title:
Comparison of Diet, Exercise, and Auricular Vagus Nerve Stimulation Efficacy for Weight Reduction in Obese Individuals
Although obesity is a rapidly increasing epidemic worldwide, it is associated with many health-related comorbidities. As a result of the developments in social life and observes the sedentary life in individuals, an effect of the age of technology the fact that this epidemic will cause even massive health problems in the coming period affecting the health systems of countries and indirectly their economies that, This situation necessitates the creation of alternative treatment methods for the prevention of obesity. This study aims to determine the effect of a therapy approach that can be applied to the vagus nervous system, which is associated with many organs and systems, on weight loss and general health. As an alternative treatment against lifestyle changes such as diet and exercise, individuals have made for weight loss.
| Status | Recruiting |
| Enrollment | 90 |
| Est. completion date | August 26, 2022 |
| Est. primary completion date | August 1, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | Inclusion Criteria: - Age range 18 - 65 - Being in the stage I, II and III obesity class Exclusion Criteria: - Those with unstable DM - Those with stage II hypertension - Those who have had cardiovascular disease (especially those who have had an attack) - Those with pulmonary disease - Those with kidney disease - Orthopedic restrictions - Those with MND - Those tied to the chair |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Avicenna Hospital | Istanbul |
| Lead Sponsor | Collaborator |
|---|---|
| Bahçesehir University |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Body Analysis | BIA measurements include (BMI (kg/m2)). | Study start | |
| Primary | Body Analysis | BIA measurements include (BMI (kg/m2)). | 2nd week | |
| Primary | Body Analysis | BIA measurements include (BMI (kg/m2)). | 4th week | |
| Primary | Body Analysis | BIA measurements include (Weight ( kg), Muscle and fat mass (kg), Body bone and fluid mass (kg), such as). | Study start | |
| Primary | Body Analysis | BIA measurements include (Weight ( kg), Muscle and fat mass (kg), Body bone and fluid mass (kg), such as). | 2nd week | |
| Primary | Body Analysis | BIA measurements include (Weight ( kg), Muscle and fat mass (kg), Body bone and fluid mass (kg), such as). | 4th week | |
| Primary | Body Analysis | BIA measurements include (Muscle and fat percentage (%) such as). | Study start | |
| Primary | Body Analysis | BIA measurements include (Muscle and fat percentage (%) such as). | 2nd week | |
| Primary | Body Analysis | BIA measurements include (Muscle and fat percentage (%) such as). | 4th week | |
| Primary | Body Analysis | BIA measurement include (Body density (mg/dl)). | Study start | |
| Primary | Body Analysis | BIA measurement include (Body density (mg/dl)). | 2nd week | |
| Primary | Body Analysis | BIA measurement include (Body density (mg/dl)). | 4th week | |
| Primary | Body Analysis | BIA measurement include (internal adiposity). | Study start | |
| Primary | Body Analysis | BIA measurement include (internal adiposity). | 2nd week | |
| Primary | Body Analysis | BIA measurement include (internal adiposity). | 4th week | |
| Primary | Anthropometric Measurements | It includes length (m) measurement. | Study start | |
| Primary | Anthropometric Measurements | It includes length (m) measurement. | 2nd week | |
| Primary | Anthropometric Measurements | It includes length (m) measurement. | 4th week | |
| Primary | Anthropometric Measurements | It includes waist (cm), hip (cm), upper arm (cm), thigh circumference (cm) and Skinfold thickness(cm) measurements. | Study start | |
| Primary | Anthropometric Measurements | It includes waist (cm), hip (cm), upper arm (cm), thigh circumference (cm) and Skinfold thickness(cm) measurements. | 2nd week | |
| Primary | Anthropometric Measurements | It includes waist (cm), hip (cm), upper arm (cm), thigh circumference (cm) and Skinfold thickness(cm) measurements. | 4th week | |
| Primary | Anthropometric Measurements | It includes waist-hip ratio measurements. | Study start | |
| Primary | Anthropometric Measurements | It includes waist-hip ratio measurements. | 2nd week | |
| Primary | Anthropometric Measurements | It includes waist-hip ratio measurements. | 4th week | |
| Primary | Biochemical parameters | It includes fasting blood sugar (mg/dL) value. | Study start & 4th week | |
| Primary | Biochemical parameters | It includes fasting blood sugar (mg/dL) value. | Study start | |
| Primary | Biochemical parameters | It includes HDL (mg/dL), LDL (mg/dL), TG (mg/dL), and Total cholesterol (mg/dL) values. | 4th week | |
| Primary | Biophysical Methods | It includes 5 X Sit-to-Stand Up test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | Study start | |
| Primary | Biophysical Methods | It includes 5 X Sit-to-Stand Up test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | 2nd week | |
| Primary | Biophysical Methods | It includes 5 X Sit-to-Stand Up test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | 4th week | |
| Primary | Biophysical Methods | It includes the Stair Climb test (sec). ( It shows the temporal variation values in performing a particular activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | Study start | |
| Primary | Biophysical Methods | It includes the Stair Climb test (sec). ( It shows the temporal variation values in performing a particular activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | 2nd week | |
| Primary | Biophysical Methods | It includes the Stair Climb test (sec). ( It shows the temporal variation values in performing a particular activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | 4th week | |
| Primary | Biophysical Methods | It includes The Timed Up and Go Test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | Study start | |
| Primary | Biophysical Methods | It includes The Timed Up and Go Test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | 2nd week | |
| Primary | Biophysical Methods | It includes The Timed Up and Go Test (sec). ( It show the temporal variation values in performing a certain activity. Functional activity and used to assess balance. Completion of test activity in a short time indicates positive development.) | 4th week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value walking distance (m). (Increased walking distance indicates that functional values develop positively.) | Study start | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value walking distance (m). (Increased walking distance indicates that functional values develop positively.) | 2nd week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value walking distance (m). (Increased walking distance indicates that functional values develop positively.) | 4th week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Blood pressure (mmHg) measurements. (High blood pressure measurements approaching the normal value indicate that functional values develop positively.) | Study start | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Blood pressure (mmHg) measurements. (High blood pressure measurements approaching the normal value indicate that functional values develop positively.) | 2nd week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Blood pressure (mmHg) measurements. (High blood pressure measurements approaching the normal value indicate that functional values develop positively.) | 4th week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Modified Borg Dyspnea and Fatigue Scores. (Decreased dyspnea and fatigue scores indicate that functional values develop positively.) | Study start | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Modified Borg Dyspnea and Fatigue Scores. (Decreased dyspnea and fatigue scores indicate that functional values develop positively.) | 2nd week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Modified Borg Dyspnea and Fatigue Scores. (Decreased dyspnea and fatigue scores indicate that functional values develop positively.) | 4th week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Heart Rate. (Heart rate values being within the normal range for age indicate that functional values develop positively.) | Study start | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Heart Rate. (Heart rate values being within the normal range for age indicate that functional values develop positively.) | 2nd week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value Heart Rate. (Heart rate values being within the normal range for age indicate that functional values develop positively.) | 4th week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value O2 saturation (mmHg). (Increased O2 saturation indicates that functional values develop positively.) | Study start | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value O2 saturation (mmHg). (Increased O2 saturation indicates that functional values develop positively.) | 2nd week | |
| Primary | 6-Min Walk Test | The 6-minute walk test includes value O2 saturation (mmHg). (Increased O2 saturation indicates that functional values develop positively.) | 4th week | |
| Primary | Handgrip strength test | The Handgrip strength test (kg) measurement evaluates muscle strength. | Study start | |
| Primary | Handgrip strength test | The Handgrip strength test (kg) measurement evaluates muscle strength. | 2nd week | |
| Primary | Handgrip strength test | The Handgrip strength test (kg) measurement evaluates muscle strength. | 4th week | |
| Secondary | International Physical Activity Questionnaire (Short Form- IPAQ) | It has been used to examine physical activity levels. (Weekly physical activity levels are measured by MET value calculations. An increase in MET values indicates an increase in activity.) | Study start, 2nd & 4th week | |
| Secondary | Quality of Life Questionnaire (Short Form - SF-36) | It was used to evaluate the effect of weight on quality of life. (It is evaluated in the range of 0 - 100 points. Energy/vitality, physical function, mental health, general health perception, social functionality scores show a positive development as they approach the maximum value. Physical role difficulty, emotional role difficulty and Pain scores show a positive development as they approach the minimum value.) | Study start, 2nd & 4th week | |
| Secondary | Food Cravings Questionnaire (FCQ) | It was used to determine the cravings for foods. (In the scale, a scoring system between 39-234 points is used for sub-dimensions.It shows that there is a positive development as the scale approaches the minimum result.) | Study start & 4th week | |
| Secondary | Visual Analog Scale (VAS) | It was used to determine the cravings for foods. (A scoring system from 0 to 10 is used.It shows that there is a positive development as the scale approaches the minimum result.) | Study start, 2nd & 4th week |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |